What is the primary test used for diagnosing suspected Zollinger-Ellison Syndrome (ZES)?

What is the primary test used for diagnosing suspected Zollinger-Ellison Syndrome (ZES)?

• A. Fasting serum gastrin
• B. Secretin stimulation test
• C. Endoscopic ultrasound
• D. Serum insulin levels

Answer: (A)

Fasting serum gastrin is the primary test used for diagnosing Zollinger-Ellison Syndrome (ZES) because this condition is characterized by excessive gastrin production, which leads to increased gastric acid secretion and recurrent peptic ulcers. When a clinician suspects ZES, measuring the levels of gastrin in the serum while the patient is fasting provides a direct indication of gastrin secretion. In patients with ZES, fasting serum gastrin levels are typically markedly elevated, distinguishing this syndrome from other conditions that may cause increased gastrin levels, such as chronic atrophic gastritis or gastric ulcers. Other tests, while they may provide additional insights, are not considered the first-line diagnostic tool. For instance, the secretin stimulation test measures the response of gastrin secretion to secretin administration, and while it can be informative, it is usually performed after initial gastrin levels are found to be elevated. Endoscopic ultrasound can be useful for evaluating gastrin-secreting tumors, but it is not a definitive diagnostic tool for ZES. Serum insulin levels are unrelated to the diagnosis of ZES and are not relevant in this context. Thus, reliance on measuring fasting serum gastrin is the most straightforward and effective initial approach to confirm a diagnosis of Zollinger-Ell

Fasting serum gastrin is the primary test used for diagnosing Zollinger-Ellison Syndrome (ZES) because this condition is characterized by excessive gastrin production, which leads to increased gastric acid secretion and recurrent peptic ulcers. When a clinician suspects ZES, measuring the levels of gastrin in the serum while the patient is fasting provides a direct indication of gastrin secretion. In patients with ZES, fasting serum gastrin levels are typically markedly elevated, distinguishing this syndrome from other conditions that may cause increased gastrin levels, such as chronic atrophic gastritis or gastric ulcers.

Other tests, while they may provide additional insights, are not considered the first-line diagnostic tool. For instance, the secretin stimulation test measures the response of gastrin secretion to secretin administration, and while it can be informative, it is usually performed after initial gastrin levels are found to be elevated. Endoscopic ultrasound can be useful for evaluating gastrin-secreting tumors, but it is not a definitive diagnostic tool for ZES. Serum insulin levels are unrelated to the diagnosis of ZES and are not relevant in this context. Thus, reliance on measuring fasting serum gastrin is the most straightforward and effective initial approach to confirm a diagnosis of Zollinger-Ell